medline.ch Neurologie Parkinson

	Biofeedback in Parkinson's disease: A systematic review with meta-analysis. Clin Rehabil Baumgart A, Preston E, Ada L, Alvarenga MTM, de Mondença JF, Flynn A. PMID: 42640577 [PubMed - as supplied by publisher]
	Ceftriaxone's Multifaceted Neuroprotection in Parkinson's Disease: Preclinical Evidence and Implications for Drug Repurposing. Drug Des Devel Ther Wen P, Dou L, Yang X, Han D, Wang J, Wu H, Ren C. PMID: 42638948 [PubMed - indexed for MEDLINE]
	Flavonoid-rich dietary patterns and incident hospital-recorded Parkinson's disease: a prospective UK Biobank study. Front Nutr Yang W, Chen Z, Zhang Y, Peng C, Chen B. PMID: 42638917 [PubMed]
	Icariside II in Neurological Disorders: Mechanistic Insights Into Alzheimer's Disease, Cerebral Ischemia and Parkinson's Disease. J Biochem Mol Toxicol Solanki A, Sharma K, Jain J, Singh NK, Krishnamurthy PT. PMID: 42638569 [PubMed - indexed for MEDLINE]
	Early Detection of Parkinson's Disease Using Automatic Classification of Single-photon Emission Computed Tomography Images. Healthc Inform Res Boucherouite J, Jilbab A, Jbari A. PMID: 42638365 [PubMed]
	Multimodal PET Imaging Unveils Early Metabolic Compensation Mechanisms and Dopaminergic Degeneration in Parkinson's Disease. Cerebellum Li S, Lu WZ, Yan SZ, Song TB, Zhang C, Yang C, Lu J. PMID: 42637971 [PubMed - indexed for MEDLINE]
	Letter to the editor concerning "Differential effects of hormone therapy formulations on Parkinson's disease risk: a systematic review and meta-analysis". Neurol Sci Carty MJ, Jarvis E, Hansen W. PMID: 42637936 [PubMed - in process]
	Comparative outcomes and healthcare costs of three device-aided pharmacotherapies for patients with advanced Parkinson's disease in Sweden: A nationwide registry-based cohort study. Parkinsonism Relat Disord Nyholm D, Paonessa D, Bergquist F, Timmermann JE, Vahteristo M, Lybæk V, Wennberg A, Odin P. PMID: 42636761 [PubMed - as supplied by publisher]
	Quality Evaluation Using the Mobile App Rating Scale for Speech Therapy in Parkinson Disease: Systematic Search and Evaluation. JMIR Form Res Haris T, Shah H, Florez-Arango JF. PMID: 42636437 [PubMed - indexed for MEDLINE]
	Neuronal Antibodies in Patients With Atypical Parkinsonism. Neurol Neuroimmunol Neuroinflamm Kerstens J, Dopper EGP, Kaat LD, Meeter LH, De Graaff E, de Vries JM, Crijnen YS, Van Steenhoven RW, Veenbergen S, Fransen N, Franken SC, Nagtzaam MMP, Erdag Turgeon E, Seelaar H, Van Swieten JC, Hoogland MA, Verbeek MM, Bloem BR, Sillevis Smitt PAE, Boon AJW, van de Warrenburg BPC, Titulaer MJ. PMID: 42636415 [PubMed - indexed for MEDLINE]
	Immediate effects and perceptions of cane use on mobility in individuals with Parkinson's disease. Disabil Rehabil Magalhães JP, Scianni AA, Ribeiro MEBS, Dias LE, Landers MR, Faria CD. PMID: 42633763 [PubMed - as supplied by publisher]
	The Improvement Effects of Virtual Reality-Assisted Exercise Training on Motor and Psychiatric Symptoms in Patients With Parkinson's Disease: A Meta-Analysis of Randomized Controlled Trials. Actas Esp Psiquiatr Zhang H, Yuan X. PMID: 42633503 [PubMed - indexed for MEDLINE]
	Magnetoreceptive CRY/MagR complexes: linking circadian redox signalling to protein aggregation in Alzheimer's and Parkinson's disease. ADMET DMPK Alipour M, Hajipour-Verdom B, Ashrafi F, Roodsari SR, Nohesara S, Zali A, Ashrafi F. PMID: 42633327 [PubMed]
	The interplay of air pollution with plasma neurodegenerative markers and metabolome for dementia, Parkinson's disease and all-cause mortality risks and transitions: The UK Biobank study. Ecotoxicol Environ Saf Beydoun MA, Huang T, Hu YH, Weiss J, Georgescu MF, Noren Hooten N, Fanelli-Kuczmarski MT, Beydoun HA, Song M, Launer LJ, Evans MK, Zonderman AB. PMID: 42632170 [PubMed - as supplied by publisher]
	Non-invasive neuromodulation for LUTS in Parkinson's disease: a comprehensive systematic review and meta-analysis of tibial nerve stimulation with GRADE evaluation. Acta Neurol Belg Abo-Elsoad MF, Abbas AW, Abou Elezz AM, Abo Zaid M, Ahmed AN, Hewezy O, Talkhan A. PMID: 42631842 [PubMed - as supplied by publisher]
	Frailty in Parkinson's disease: time to integrate it into treatment decision-making? J Neural Transm (Vienna) Auffret M, Fazio C, Johansson A, Pisani A, Odin P, Santens P, Lorenzl S. PMID: 42631724 [PubMed - as supplied by publisher]
	Multimodal Neuroimaging-Based Machine Learning Models Leveraging Cerebral Morphometry and Glymphatic Parameters Predict Short-Term Post-Programming STN-DBS Motor Response in Parkinson's Disease. CNS Neurosci Ther Wang Y, Zhang X, Yu W, Yang Y, Cai J, He J, Miao H, Li L, Lang L, Hu J, Qi Z, Chen L. PMID: 42631338 [PubMed - indexed for MEDLINE]
	Comparative risks of dementia and Parkinson's disease with GLP-1 RAs versus other oral glucose-lowering medications in obese patients with type 2 diabetes: a large real-world cohort study. Eur J Intern Med Abu Ahmad W, Wolff Sagy Y, Arbel R, Battat E, Dicker D, Lavie G, Reges O. PMID: 42629262 [PubMed - as supplied by publisher]
	Neuroinflammation and vaccination strategy in Parkinson's disease. Adv Immunol Yukti, Sharma S, Dubey AK, Sharma A, Prajapati VK. PMID: 42629133 [PubMed - indexed for MEDLINE]
	Microglial polarisation imbalance and receptor-targeted therapeutics in Parkinson's disease. Adv Immunol Upadhyay R, Sevanan M. PMID: 42629131 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 58619

Seite 1 von 2931

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung